SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-177520
Filing Date
2015-05-08
Accepted
2015-05-07 18:07:27
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d899387d10q.htm 10-Q 484891
2 EX-10.5 d899387dex105.htm EX-10.5 10746
3 EX-31.1 d899387dex311.htm EX-31.1 6783
4 EX-31.2 d899387dex312.htm EX-31.2 6732
5 EX-32.1 d899387dex321.htm EX-32.1 4819
  Complete submission text file 0001193125-15-177520.txt   3761824

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgls-20150331.xml EX-101.INS 423824
7 XBRL TAXONOMY EXTENSION SCHEMA rgls-20150331.xsd EX-101.SCH 33259
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20150331_cal.xml EX-101.CAL 45107
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20150331_def.xml EX-101.DEF 218591
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20150331_lab.xml EX-101.LAB 299159
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20150331_pre.xml EX-101.PRE 252226
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 15843376
SIC: 2834 Pharmaceutical Preparations